M.Sc Jędrzej Gromadecki

Arxada

Marketing Director

Current lectures/posters

15.10.2026

12:30

-

13:00

-

The Role of Environmental Disinfection in Mitigating Multidrug-resistant Pathogen Transmission in Healthcare Settings.

(available in the SOFW media library after the congress)

Lecture Language: English

In the face of the escalating antimicrobial resistance (AMR) crisis, surface disinfection has become a critical link in breaking transmission chains. This lecture analyzes the role of the hospital environment as a reservoir for multidrug-resistant organisms (MDROs), such as MRSA, CRE, and Candida auris, which exhibit the ability to persist long-term on high-touch surfaces.
Special attention is given to microbial defense mechanisms, particularly biofilm structures. Research indicates that bacteria within biofilms require significantly higher concentrations of active substances than planktonic forms, posing a substantial challenge to standard hygiene procedures. The results of network meta-analyses are discussed, confirming that intervention bundles integrating environmental disinfection with rigorous precautions achieve exceptionally low pathogen transmission rates.
The lecture also addresses the innovative topic of pathogen adaptation to biocidal substances. Using Pseudomonas aeruginosa as a model, the application of the Karpiński Adaptation Index (KAI) is presented to quantitatively assess the risk of resistance development against commonly used chemical compounds. Furthermore, the relationship between microbiological efficacy and material compatibility is analyzed, including how surface corrosion facilitates microbial adhesion and subsequent biofilm formation.
In conclusion, the lecture discusses selection criteria for modern biocidal agents that combine a full spectrum of efficacy with high material compatibility. The toxicological profile of next-generation formulations is analyzed, focusing on solutions that minimize the formation of carcinogenic organic compounds and reduce personnel exposure to respiratory irritants and airborne aerosols.

45 | Comparative Analysis of High-Level Disinfectants in the Eradication of Microbial Biofilms on Healthcare Surfaces

Microbial biofilms represent a significant challenge in healthcare environments due to their high tolerance to conventional chemical agents. This poster presents a comparative analysis of high-level disinfectants (HLD), focusing on the efficacy of traditional oxidizers – such as sodium hypochlorite (bleach), peracetic acid (PAA), and hydrogen peroxide H2O2 – in comparison to stabilized chlorine dioxide formulations.
The study emphasizes that while HLDs are typically highly reactive oxidizing agents, their real-world performance is heavily influenced by product formulation and delivery methods.
The comparison highlights that while sodium hypochlorite is a standard treatment, its limitations include poor material compatibility and the potential formation of carcinogenic organic compounds. In contrast, stabilized chlorine dioxide formulations offer a robust alternative, demonstrating high anti-biofilm activity and material compatibility. Furthermore, the analysis applies dual evaluation criteria: the ability to kill pathogens within the biofilm and the physical removal of the biological matrix from the surface. By assessing overall product performance rather than just active ingredient concentration, this presentation provides a scientific framework for selecting disinfection technologies that balance high-level antimicrobial efficacy with user safety and surface compatibility.

111 | Advanced performic acid technology: revolutionizing point-of-use disinfectant for impregnating dry wipes at point of use.

In healthcare and high-touch industrial environments, mitigating the transmission of healthcare-associated infections (HAIs) requires rapid, uncompromised efficacy against high-threat pathogens. Microorganisms not sensitive to standard disinfection protocols, particularly bacterial spores like Clostridium difficile, pose a critical challenge to conventional surface hygiene regimens. This presentation introduces Quanticare® PFA, an innovative disinfectant cleaner engineered to bridge the gap between high-level biocidal performance and bridging the gap between latest efficacy requirements and good cleaning performance and material compatibility.

Quanticare® PFA utilizes advanced performic acid (PFA) chemistry generated
in-situ through a two-part system combining formic acid and hydrogen peroxide. This technology is specifically engineered for the impregnation of dry wipes at the point of use. This not only improves the shelf life but contributes to maintain a high performance across broad range of commercially available dry wipes.

Crucially, the formulation achieves an uncompromising, full spectrum of efficacy within a rigorous 5-minute contact time, verified under demanding “medical dirty” conditions. It complies with the latest European standards, including bactericidal (EN 13727, EN 16615), fungicidal (EN 13624, EN 16615), virucidal (EN 14476), and mycobactericidal (EN 14348, EN 16615) requirements. Most notably, its high-level sporicidal integrity is validated via EN 17126 suspension tests and EN 17846 carrier tests, which simulate real-world surface applications.

Designed as a dual-use solution fulfilling both the Medical Device Regulation (MDR Class IIb) and the Biocidal Products Regulation (BPR), Quanticare® PFA provides a one-step solution for high-touch areas cleaning and disinfection. It delivers broad material compatibility across medical-grade plastics and metals alongside a low-odour profile, ensuring safety, compliance, and clinical efficiency.